Works matching IS 17528054 AND DT 2022 AND VI 15 AND IP 9
Results: 19
Perceptions of pharmacogenetic exceptionalism and the implications for clinical management within an electronic health record.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2265, doi. 10.1111/cts.13360
- By:
- Publication type:
- Article
Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2251, doi. 10.1111/cts.13359
- By:
- Publication type:
- Article
The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver disease.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2241, doi. 10.1111/cts.13358
- By:
- Publication type:
- Article
Alternatives to rifampicin: A review and perspectives on the choice of strong CYP3A inducers for clinical drug–drug interaction studies.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2075, doi. 10.1111/cts.13357
- By:
- Publication type:
- Article
A risk scoring system integrating postoperative factors for predicting early mortality after major non‐cardiac surgery.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2230, doi. 10.1111/cts.13356
- By:
- Publication type:
- Article
Model‐informed drug development for immuno‐oncology agonistic anti‐GITR antibody GWN323: Dose selection based on MABEL and biologically active dose.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2218, doi. 10.1111/cts.13355
- By:
- Publication type:
- Article
Estimation of glomerular filtration rate for drug dosing in patients with very high or low body mass index.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2206, doi. 10.1111/cts.13354
- By:
- Publication type:
- Article
Assessment of drug–drug interaction potential with EDP‐305, a farnesoid X receptor agonist, in healthy subjects.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2146, doi. 10.1111/cts.13348
- By:
- Publication type:
- Article
Investigation of CYP3A induction by PF‐05251749 in early clinical development: comparison of linear slope physiologically based pharmacokinetic prediction and biomarker response.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2184, doi. 10.1111/cts.13352
- By:
- Publication type:
- Article
Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2172, doi. 10.1111/cts.13351
- By:
- Publication type:
- Article
A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2159, doi. 10.1111/cts.13350
- By:
- Publication type:
- Article
Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T‐cellular therapy development.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2057, doi. 10.1111/cts.13349
- By:
- Publication type:
- Article
Erythropoiesis‐stimulating agents and incident malignancy in chronic kidney and end‐stage renal disease: A population‐based study.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2195, doi. 10.1111/cts.13353
- By:
- Publication type:
- Article
Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2135, doi. 10.1111/cts.13347
- By:
- Publication type:
- Article
Going beyond bibliometrics: A system to track the progress and impact of biomedical research funded by Susan G. Komen.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2127, doi. 10.1111/cts.13346
- By:
- Publication type:
- Article
Changing the drug development and therapeutic paradigm with biologic drug combinations and bispecifics: How to choose between these two approaches?
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2096, doi. 10.1111/cts.13345
- By:
- Publication type:
- Article
The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2116, doi. 10.1111/cts.13344
- By:
- Publication type:
- Article
Serious arrhythmia in initiators of citalopram, escitalopram, and other selective serotonin reuptake inhibitors: A population‐based cohort study in older adults.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2105, doi. 10.1111/cts.13319
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2053, doi. 10.1111/cts.13138
- Publication type:
- Article